American Journal Of Pathology · 1998 · 25 citations · 34 references
MedicineNephrologyPathologyCellular PathologyMolecular PathologyRenal PathologyBone Marrow PathologyGlomerular DiseasesHematologic PathologyHereditary Renal DiseasesRenal ImmunopathologyHeavy Chain DiseaseImmunoglobulin Light Chain DiseaseImmunoglobulin Light Chain RearrangementKidney Biopsy FindingsLight Chain DepositionLight Chain StructureMonoclonal Immunoglobulin Deposition DiseaseMyeloma Pathogenesis
We herein report on the first two primary sequences (BOU and RAC) of monoclonal light chains of the λ type responsible for nonamyloid λ light chain deposition disease. Both patients were affected with severe forms of myeloma complicated with renal failure. The pathological presentation typically featured Congo red-negative deposits along tubular basement membranes but differed somewhat from the typical “Randall-type” κ light chain deposition disease: they lacked the prominent glomerulosclerosis pattern often featuring nonamyloid κ deposits and were associated with cylinders or myeloma casts. Both protein sequences were deduced from those of the corresponding complementary DNAs in the bone marrow plasma cells. For each chain, products of three independent amplifications by polymerase chain reaction were sequenced and found to be identical. BOU and RAC λ mRNAs had a normal overall structure consisting of Vλ2 segments rearranged to Jλ2Cλ2 but displayed a number of unusual features within their primary sequences. These substitutions are likely responsible for changes in light chain conformation that promote their aggregation and deposition along renal tubule basement membranes. We herein report on the first two primary sequences (BOU and RAC) of monoclonal light chains of the λ type responsible for nonamyloid λ light chain deposition disease. Both patients were affected with severe forms of myeloma complicated with renal failure. The pathological presentation typically featured Congo red-negative deposits along tubular basement membranes but differed somewhat from the typical “Randall-type” κ light chain deposition disease: they lacked the prominent glomerulosclerosis pattern often featuring nonamyloid κ deposits and were associated with cylinders or myeloma casts. Both protein sequences were deduced from those of the corresponding complementary DNAs in the bone marrow plasma cells. For each chain, products of three independent amplifications by polymerase chain reaction were sequenced and found to be identical. BOU and RAC λ mRNAs had a normal overall structure consisting of Vλ2 segments rearranged to Jλ2Cλ2 but displayed a number of unusual features within their primary sequences. These substitutions are likely responsible for changes in light chain conformation that promote their aggregation and deposition along renal tubule basement membranes. A number of diseases may result from monoclonal immunoglobulin (Ig) tissue deposition complicating malignant or benign monoclonal B cell proliferations. These diseases are characterized by multivisceral Ig-related material deposits, most often corresponding to monoclonal light chains (LCs) or LC fragments and usually predominating in the kidney. The two most frequent pathological presentations are AL-amyloidosis and nonamyloid (Randall-type) LC deposition disease (LCDD): AL-amyloidosis deposits usually predominate in the glomerular mesangium and in arteriolar walls and mostly involve λ LCs highly organized in β-pleated sheet fibrils. By contrast, LCDD deposits (mostly of the κ type) are amorphous, predominate along the outer part of basement membranes in the distal tubule and the loop of Henlé, and often associate with marked nodular glomerulosclerosis.1Preud'homme JL Morel-Maroger L Brouet JC Cerf M Mignon F Guglielmi P Seligmann M Synthesis of abnormal immunoglobulins in lymphoplasmatic disorders with visceral light chain deposition.Am J Med. 1980; 69: 703-710Abstract Full Text PDF PubMed Scopus (88) Google Scholar, 2Preud'homme JL Morel-Maroger L Brouet JC Mihaesco E Mery JP Seligmann M Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.Clin Exp Immunol. 1980; 42: 545-553PubMed Google Scholar, 3Ganeval D Noël LH Preud'homme JL Droz D Grünfeld JP Light chain deposition disease: its relation with AL-type amyloidosis.Kidney Int. 1984; 26: 1-9Crossref PubMed Scopus (169) Google Scholar, 4Bellotti V Stoppini M Merlini G Zapponi MC Meloni ML Banfi G Ferri G Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.Biochim Biophys Acta. 1991; 1097: 177-182Crossref PubMed Scopus (30) Google Scholar, 5Cogné M Preud'homme JL Bauwens M Touchard G Aucouturier P Structure of a monoclonal κ chain of the VκIV subgroup in the kidney and plasma cells in light chain deposition disease.J Clin Invest. 1991; 87: 2186-2190Crossref PubMed Scopus (75) Google Scholar, 6Cogné M Silvain C Khamlichi AA Preud'homme JL Structurally abnormal immunoglobulins in human immunoproliferative disorders.Blood. 1992; 79: 2181-2195PubMed Google Scholar, 7Khamlichi AA Aucouturier P Silvain C Bauwens M Touchard G Preud'homme JL Nau F Cogné M Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1992; 87: 122-126Crossref PubMed Scopus (42) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 9Preud'homme JL Aucouturier P Touchard G Khamlichi AA Rocca A Denoroy L Cogné M Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations.Int J Immunopharmacol. 1994; 16: 425-431Crossref PubMed Scopus (23) Google Scholar, 10Denoroy L Déret S Aucouturier P Overrepresentation of the VκIV subgroup in light chain deposition disease.Immunol Lett. 1994; 42: 63-66Crossref PubMed Scopus (71) Google Scholar, 11Decourt C Cogné M Rocca A Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1996; 106: 357-361Crossref PubMed Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar, 13Gallo G Goni F Boctor F Vidal R Kumar A Stevens FJ Frangione B Ghiso J Light chain cardiomyopathy: structural analysis of the light chain tissue deposits.Am J Pathol. 1996; 148: 1397-1406PubMed Google Scholar, 14Bellotti V Stoppini M Magione PM Fornasieri A Min L Merlini G Ferri G Structural and functional characterization of three human immunoglobulin k light chains with different pathological implications.Biochim Biophys Acta. 1996; 1317: 161-167Crossref PubMed Scopus (25) Google Scholar To date, many LCs implicated in AL-amyloidosis have been described, and a large amount of sequence data has allowed the formulation of hypotheses concerning the special role of some amino acid substitutions in the process of fibril formation.15Aucouturier P Khamlichi AA Preud'homme J Bauwens M Touchard G Cogné M Complementary DNA sequence of human amyloidogenic immunoglobulin light chain precursors.Biochem J. 1992; 285: 149-152Crossref PubMed Scopus (28) Google Scholar, 16Hurle MR Helms LR Li L Chan W Wetzel R A role for destabilizing amino acid replacements in light chain amyloidosis.Proc Natl Acad Sci USA. 1994; 91: 5446-5450Crossref PubMed Scopus (329) Google Scholar, 17Stevens PW Raffen R Hanson DK Deng YL Berrios-Hammond M Westholm FA Murphy C Eulitz M Wetzel R Solomon A Schiffer M Stevens F Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.Protein Sci. 1995; 4: 421-432Crossref PubMed Scopus (107) Google Scholar, 18Stevens F Myatt EA Chang C-H Westholm FA Eulitz M Weiss DT Murphy C Solomon A Schiffer M A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains.Biochemistry. 1995; 34: 10697-10702Crossref PubMed Scopus (101) Google Scholar, 19Helms LR Wetzel R Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis.J Mol Biol. 1996; 257: 77-86Crossref PubMed Scopus (97) Google Scholar, 20Schorman N Murrell JR Lipnieks JJ Benson MD Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.Proc Natl Acad Sci USA. 1995; 92: 9490-9494Crossref PubMed Scopus (79) Google Scholar By contrast, only a few LCDD chains have been studied, all of the κ type,4Bellotti V Stoppini M Merlini G Zapponi MC Meloni ML Banfi G Ferri G Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.Biochim Biophys Acta. 1991; 1097: 177-182Crossref PubMed Scopus (30) Google Scholar, 5Cogné M Preud'homme JL Bauwens M Touchard G Aucouturier P Structure of a monoclonal κ chain of the VκIV subgroup in the kidney and plasma cells in light chain deposition disease.J Clin Invest. 1991; 87: 2186-2190Crossref PubMed Scopus (75) Google Scholar, 7Khamlichi AA Aucouturier P Silvain C Bauwens M Touchard G Preud'homme JL Nau F Cogné M Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1992; 87: 122-126Crossref PubMed Scopus (42) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 9Preud'homme JL Aucouturier P Touchard G Khamlichi AA Rocca A Denoroy L Cogné M Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations.Int J Immunopharmacol. 1994; 16: 425-431Crossref PubMed Scopus (23) Google Scholar, 11Decourt C Cogné M Rocca A Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1996; 106: 357-361Crossref PubMed Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar, 13Gallo G Goni F Boctor F Vidal R Kumar A Stevens FJ Frangione B Ghiso J Light chain cardiomyopathy: structural analysis of the light chain tissue deposits.Am J Pathol. 1996; 148: 1397-1406PubMed Google Scholar and the process by which LCs aggregate is still largely unknown. We herein report on the first two λ LCs (BOU andRAC) implicated in nonamyloid LCDD. BOU andRAC belonged to the Vλ2 subgroup and included Jλ2/Cλ2 segments. In both cases, the renal lesions differed somewhat from those seen in most cases of κ nonamyloid deposits, because they did not reveal prominent glomerulosclerosis. In addition, for both patients, deposits along the tubular membrane basements were accompanied by tubular lesions resembling cast myeloma. Patient BOU, a 59-year-old French man, was referred in September 1993 for renal failure with anemia (hemoglobin, 8 g/100 ml). The creatininemia was 750 μmol/L, and proteinuria was abundant (8 g/24 hours) with a predominant λ Bence-Jones protein that was also detectable in serum in small amounts. Hypo-γ-globulinemia was marked (4 g/L). A moderate microscopic hematuria was found. Bone marrow smears showed 50% plasma cells. Light microscopic examination of a kidney biopsy showed myeloma cast nephropathy. Eighteen glomeruli were normal without nodular sclerosis. The interstitium was focally infiltrated by lymphocytes and plasma cells. Congo red staining was negative. Immunofluorescence study (Figure 1A)showed linear deposits along the tubular basement membranes, which only stained for λ chain. Electron microscopic study of a renal medulla fragment was essentially normal and did not show granular osmiophilic deposits along tubular basement membranes. From October 1993 to December 1993, the patient was given nine courses of plasmapheresis and two courses of vincristine (0.4 mg) and Adriamycin (9 mg/m2) combined the first day with prednisolone (1 mg/kg), which was continued for 4 further was and the patient in December 1993 with plasma cells. Patient a was referred in September for renal failure The plasma was μmol/L, and was an abundant proteinuria to g/24 hours) essentially consisting of monoclonal λ chains that were also detectable in serum by was monoclonal or by and serum were affected of of and of Bone marrow smears showed plasma cells and allowed the of myeloma. Light microscopic examination of a kidney biopsy showed severe and tubular lesions with a moderate cell (Figure were by a were and by some tubular basement membranes were with Congo red-negative nodular glomerulosclerosis was not By (Figure tubular basement membrane deposits only stained with LC and not with chains or The patient was included in a of two bone marrow the first creatininemia to and proteinuria to g/24 The was in the serum was and the proteinuria without LC detectable in the a severe with a heavy plasma cell in bone marrow and with of λ LC in was by of bone marrow cells in 4 by for on a was on a in with from the human cell κ and from the cell a λ Preud'homme JL Cogné M Structure and of the in human Exp Immunol. 1992; PubMed Scopus Google Scholar were to and with a a fragment the human or a a fragment the human was a for and an acid were a corresponding to a region and a complementary to the part of the of the by was with polymerase consisting of for for and for S F N of sequences and analysis for of cell PubMed Scopus Google Scholar products were on and sequenced by the F S DNA with chain Natl Acad Sci USA. PubMed Scopus Google Scholar polymerase and an DNA and were by in and by For patient were in on a to by a on in in showed that the protein was in RAC protein mg) was in of and for with an of was by and The were by a and a to linear of a of sequence analysis of was on a and the amino acid were the from bone marrow cells in two cases of λ LC mRNAs by with a a the in both cases, with a in the corresponding to myeloma (Figure These data that the B cell in both bone marrow to the monoclonal cells. In both cases, three independent amplifications were and of products sequences for all three independent In addition, protein sequence analysis of RAC allowed the of sequences and which in with the protein sequence deduced From BOU and RAC amino acid sequences and both LCs to the Vλ2 In both cases, the V region was rearranged to the Jλ2Cλ2 which did not sequence the of sequences with λ chains unusual features consisting of the of or found (Figure In protein BOU, substitutions Vλ2 were and substitutions have been Vλ2 and substitutions were the and within of the BOU sequence is a within to In protein substitutions included and substitutions included and substitutions were with BOU, the and within A monoclonal LCs in all of the κ type and with an of the have been sequenced to V Stoppini M Merlini G Zapponi MC Meloni ML Banfi G Ferri G Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.Biochim Biophys Acta. 1991; 1097: 177-182Crossref PubMed Scopus (30) Google Scholar, 5Cogné M Preud'homme JL Bauwens M Touchard G Aucouturier P Structure of a monoclonal κ chain of the VκIV subgroup in the kidney and plasma cells in light chain deposition disease.J Clin Invest. 1991; 87: 2186-2190Crossref PubMed Scopus (75) Google Scholar, 7Khamlichi AA Aucouturier P Silvain C Bauwens M Touchard G Preud'homme JL Nau F Cogné M Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1992; 87: 122-126Crossref PubMed Scopus (42) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 9Preud'homme JL Aucouturier P Touchard G Khamlichi AA Rocca A Denoroy L Cogné M Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations.Int J Immunopharmacol. 1994; 16: 425-431Crossref PubMed Scopus (23) Google Scholar, 10Denoroy L Déret S Aucouturier P Overrepresentation of the VκIV subgroup in light chain deposition disease.Immunol Lett. 1994; 42: 63-66Crossref PubMed Scopus (71) Google Scholar, 11Decourt C Cogné M Rocca A Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1996; 106: 357-361Crossref PubMed Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar We herein two λ chains deposits in The BOU andRAC LCs were responsible for nonamyloid LC deposits to tubular membrane both cases lacked the prominent glomerulosclerosis that often features κ nonamyloid LCDD. has been that morphological changes were often severe and nodular was frequent in λ LCDD in κ LCDD LCDD cases in the EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar only by without morphological of the kidney have also been in an model of κ LCDD that an of the AA Rocca A Touchard G Aucouturier P Preud'homme JL Cogné M of light chain variable region in myeloma with light chain deposition disease: from an 1995; Google Scholar The of LCDD and myeloma that report in patient BOU also to be unusual and was only in of 24 patients with LCDD in the study of EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar both chains are to the Vλ2 G and of human immunoglobulin J Immunol. 1993; PubMed Scopus Google Scholar and by a rearranged to and to P Structure and of the human immunoglobulin Exp Med. PubMed Scopus Google Scholar given their BOU and sequences likely from two different of the Vλ2 BOU is mostly to the S E A JL J N sequence analysis of the human immunoglobulin PubMed Scopus Google Scholar RAC is mostly to G and of human immunoglobulin J Immunol. 1993; PubMed Scopus Google Scholar of but they a number of features Vλ2 RAC and BOU a few amino acid and both replacements The BOU sequence unusual features within the variable both in and in complementary A of BOU is a within the the and to the of EA M light chains and of of of and which had been found in chain. the loop and may its which is in λ C for the of Mol Biol. PubMed Scopus Google Scholar from the changes were also in the with and two amino acid In and may the structure by the of the C for the of Mol Biol. PubMed Scopus Google Scholar for the or substitutions in the in the and and in the The and substitutions have a on the protein is that the is to BOU and RAC and an implicated in the of the loop C for the of Mol Biol. PubMed Scopus Google Scholar The in both of an in BOU and from a in may also be most LCs a in the of a to usually V FJ Schiffer M Structure and of human immunoglobulin light-chain Mol Biol. 1995; Google Scholar unusual features and RAC are the of a the of the the and a in the a features all κ LCDD sequenced to of the unusual features of protein RAC from those of the and were the three and and two and amino in the and the an and likely destabilizing the chain an in the and two substitutions within the and The herein BOU and RAC λ chain sequences are the first to be in in which monoclonal κ chains The of V region peculiarities in LC BOU and RAC was from sequence analysis of LCDD κ V Stoppini M Merlini G Zapponi MC Meloni ML Banfi G Ferri G Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.Biochim Biophys Acta. 1991; 1097: 177-182Crossref PubMed Scopus (30) Google Scholar, 5Cogné M Preud'homme JL Bauwens M Touchard G Aucouturier P Structure of a monoclonal κ chain of the VκIV subgroup in the kidney and plasma cells in light chain deposition disease.J Clin Invest. 1991; 87: 2186-2190Crossref PubMed Scopus (75) Google Scholar, 7Khamlichi AA Aucouturier P Silvain C Bauwens M Touchard G Preud'homme JL Nau F Cogné M Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1992; 87: 122-126Crossref PubMed Scopus (42) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 11Decourt C Cogné M Rocca A Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1996; 106: 357-361Crossref PubMed Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar and from for the of V region in a model of human κ AA Rocca A Touchard G Aucouturier P Preud'homme JL Cogné M of light chain variable region in myeloma with light chain deposition disease: from an 1995; Google Scholar is that the herein λ chains are By to the of chains in may be to that of some Vλ2 domains may promote LC aggregation and is that the Vλ2 subgroup is in myeloma and of monoclonal of of from normal A Weiss DT V region of human λ light Immunol. Google Scholar, S M D Weiss DT Solomon A of human chain variable region in multiple and 1994; PubMed Scopus Google Scholar and is that not all chains are responsible for LCDD. In addition, a AL-amyloidosis cases Vλ2 subgroup LC have been A Weiss DT V region of human λ light Immunol. Google Scholar, G J The primary structure of a light-chain amyloid fibril protein J. Google Scholar, G J Frangione B of renal amyloid from the variable region of the light chain subgroup J Pathol. Google Scholar, P The amino acid sequence of a J. Google Scholar A likely is that the sequences may LC aggregation in some to but that a role in the process of tissue deposition in patients BOU andRAC is by amino acid replacements from and LC or replacements further promote the and deposition of is and RAC λ chains a number of unusual of of the be for a of substitutions to of the in the part of the in BOU and and in RAC) or in and in BOU, and in RAC) are likely to the of both LCs and may a destabilizing may in to aggregation and promote tissue substitutions in of LCs have been for κ LCs implicated in V Stoppini M Merlini G Zapponi MC Meloni ML Banfi G Ferri G Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease.Biochim Biophys Acta. 1991; 1097: 177-182Crossref PubMed Scopus (30) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 11Decourt C Cogné M Rocca A Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1996; 106: 357-361Crossref PubMed Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar for LCs in amyloid fibril formation.15Aucouturier P Khamlichi AA Preud'homme J Bauwens M Touchard G Cogné M Complementary DNA sequence of human amyloidogenic immunoglobulin light chain precursors.Biochem J. 1992; 285: 149-152Crossref PubMed Scopus (28) Google Scholar, 16Hurle MR Helms LR Li L Chan W Wetzel R A role for destabilizing amino acid replacements in light chain amyloidosis.Proc Natl Acad Sci USA. 1994; 91: 5446-5450Crossref PubMed Scopus (329) Google Scholar, 17Stevens PW Raffen R Hanson DK Deng YL Berrios-Hammond M Westholm FA Murphy C Eulitz M Wetzel R Solomon A Schiffer M Stevens F Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.Protein Sci. 1995; 4: 421-432Crossref PubMed Scopus (107) Google Scholar These sequences the of characterized LCs in cases and to the process by which LCs of or aggregate in and deposits in also likely that structural of a given LC are to the of visceral deposition in the patient and to the In that the herein λ LCDD cases with of the LC and pathological with many κ LCDD cases in which or of the LC is associated with visceral deposition and renal morphological M Preud'homme JL Bauwens M Touchard G Aucouturier P Structure of a monoclonal κ chain of the VκIV subgroup in the kidney and plasma cells in light chain deposition disease.J Clin Invest. 1991; 87: 2186-2190Crossref PubMed Scopus (75) Google Scholar, 7Khamlichi AA Aucouturier P Silvain C Bauwens M Touchard G Preud'homme JL Nau F Cogné M Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease.Clin Exp Immunol. 1992; 87: 122-126Crossref PubMed Scopus (42) Google Scholar, 8Rocca A Khamlichi AA Aucouturier P Noël LH Denoroy L Preud'homme JL Cogné M Primary structure of a variable region of the VκI subgroup (ISE) in light chain deposition disease.Clin Exp Immunol. 1993; 91: 506-509Crossref PubMed Scopus (49) Google Scholar, 9Preud'homme JL Aucouturier P Touchard G Khamlichi AA Rocca A Denoroy L Cogné M Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations.Int J Immunopharmacol. 1994; 16: 425-431Crossref PubMed Scopus (23) Google Scholar, 12Strøm EH Fogazzi GB Banfi G Pozzi C Mihatsch MJ Light chain deposition disease of the kidney: morphological aspects in 24 patients.Virchows Arch. 1994; 425: 271-280Crossref PubMed Scopus (57) Google Scholar, 13Gallo G Goni F Boctor F Vidal R Kumar A Stevens FJ Frangione B Ghiso J Light chain cardiomyopathy: structural analysis of the light chain tissue deposits.Am J Pathol. 1996; 148: 1397-1406PubMed Google Scholar, 14Bellotti V Stoppini M Magione PM Fornasieri A Min L Merlini G Ferri G Structural and functional characterization of three human immunoglobulin k light chains with different pathological implications.Biochim Biophys Acta. 1996; 1317: 161-167Crossref PubMed Scopus (25) Google Scholar We Stevens for on λ LC sequences.
34
One-megabase sequence analysis of the human immunoglobulin lambda gene locus.
Kazuhiko Kawasaki, Satoshi Minoshima, Eriko Nakato et al. · Genome Research · 1997 · 210 citations